INS and liver dysplastic nodule: Interestingly, the bioluminescence signal was significantly reduced in moderate-dose STZ-induced mice after insulin treatment (Figure 4A,B), thereby suggesting the reliability of using the Saa3 promoter-luc mouse kidney in monitoring DN progression and exploring therapeutic agents and functional foods.